New cytomegalovirus antiviral therapy: unlocking future prospects in treating cytomegalovirus-induced hemophagocytic lymphohistiocytosis

被引:0
作者
Rolsdorph, Linn asholt [1 ]
Reikvam, Hakon [2 ,3 ]
机构
[1] Akershus Univ Hosp, Dept Med, Lorenskog, Norway
[2] Haukeland Hosp, Dept Med, Bergen, Norway
[3] Univ Bergen, KG Jebsen Ctr Myeloid Blood Canc, Dept Clin Sci, Bergen 1, N-5021 Bergen, Norway
关键词
Hemophagocytic lymphohistiocytosis; cytomegalovirus; immunotherapy; antiviral therapy; LETERMOVIR; PROPHYLAXIS;
D O I
10.1080/14656566.2025.2456586
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:231 / 234
页数:4
相关论文
共 19 条
  • [11] McClain KL., TREATMENT PROGNOSIS
  • [12] Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
    Papanicolaou, Genovefa A.
    Silveira, Fernanda P.
    Langston, Amelia A.
    Pereira, Marcus R.
    Avery, Robin K.
    Uknis, Marc
    Wijatyk, Anna
    Wu, Jingyang
    Boeckh, Michael
    Marty, Francisco M.
    Villano, Stephen
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (08) : 1255 - 1264
  • [13] A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant
    Raglow, Zoe
    Kaul, Daniel R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (01): : 27 - 29
  • [14] Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
    Razonable, Raymund R.
    Humar, Atul
    [J]. CLINICAL TRANSPLANTATION, 2019, 33 (09)
  • [15] Concomitant Hemophagocytic Lymphohistiocytosis and Cytomegalovirus Disease: A Case Based Systemic Review
    Rolsdorph, Linn asholt
    Mosevoll, Knut Anders
    Helgeland, Lars
    Reikvam, Hakon
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [16] Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients
    Saullo, Jennifer L.
    Miller, Rachel A.
    [J]. ANNUAL REVIEW OF MEDICINE, 2023, 74 : 89 - 105
  • [17] Letermovir and HCT: too much of a good thing?
    Schleiss, Mark R.
    [J]. BLOOD, 2021, 138 (01) : 1 - 2
  • [18] New Treatment Options for Refractory/Resistant CMV Infection
    Walti, Carla Simone
    Khanna, Nina
    Avery, Robin K.
    Helantera, Ilkka
    [J]. TRANSPLANT INTERNATIONAL, 2023, 36
  • [19] Wingard JR., PREVENTION VIRAL INF